Rainmed: April 2026 Return Signals Unchanged Share Capital and 21.72 Million Outstanding Options

Bulletin Express05-04

Rainmed Medical Limited (Rainmed) filed its monthly return for the period ended 30 April 2026 with the Hong Kong Stock Exchange on 4 May 2026, confirming stable equity metrics and no share-capital movements during the month.

• Authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD0.0001, equivalent to HKD0.38 million.

• Issued share capital was unchanged at 1.40 billion shares, and the company held no treasury shares. Rainmed affirmed compliance with the Main Board’s 25% minimum public-float requirement.

• Under the Pre-IPO Share Option Scheme adopted on 10 December 2021, 21.72 million options with an exercise price of HKD3.90 were outstanding, representing a potential dilution of approximately 1.55% of the current issued share base. No options were exercised, granted, or cancelled in April.

• The company reported no warrants, convertible securities, Hong Kong depositary receipts, or other equity-linked instruments in issue, and no movements in treasury shares.

The filing includes standard confirmations that any securities activities comply with the Listing Rules and all relevant legal and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1129697107?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129697107","market":"hk","top_or_hot":-1,"title":"Rainmed: April 2026 Return Signals Unchanged Share Capital and 21.72 Million Outstanding Options","media":"Bulletin Express","content":"<p>Rainmed Medical Limited (Rainmed) filed its monthly return for the period ended 30 April 2026 with the Hong Kong Stock Exchange on 4 May 2026, confirming stable equity metrics and no share-capital movements during the month.</p>\n<p>• Authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD0.0001, equivalent to HKD0.38 million.</p>\n<p>• Issued share capital was unchanged at 1.40 billion shares, and the company held no treasury shares. Rainmed affirmed compliance with the Main Board’s 25% minimum public-float requirement.</p>\n<p>• Under the Pre-IPO Share Option Scheme adopted on 10 December 2021, 21.72 million options with an exercise price of HKD3.90 were outstanding, representing a potential dilution of approximately 1.55% of the current issued share base. No options were exercised, granted, or cancelled in April.</p>\n<p>• The company reported no warrants, convertible securities, Hong Kong depositary receipts, or other equity-linked instruments in issue, and no movements in treasury shares.</p>\n<p>The filing includes standard confirmations that any securities activities comply with the Listing Rules and all relevant legal and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rainmed: April 2026 Return Signals Unchanged Share Capital and 21.72 Million Outstanding Options</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRainmed: April 2026 Return Signals Unchanged Share Capital and 21.72 Million Outstanding Options\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-04 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Rainmed Medical Limited (Rainmed) filed its monthly return for the period ended 30 April 2026 with the Hong Kong Stock Exchange on 4 May 2026, confirming stable equity metrics and no share-capital movements during the month.</p>\n<p>• Authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD0.0001, equivalent to HKD0.38 million.</p>\n<p>• Issued share capital was unchanged at 1.40 billion shares, and the company held no treasury shares. Rainmed affirmed compliance with the Main Board’s 25% minimum public-float requirement.</p>\n<p>• Under the Pre-IPO Share Option Scheme adopted on 10 December 2021, 21.72 million options with an exercise price of HKD3.90 were outstanding, representing a potential dilution of approximately 1.55% of the current issued share base. No options were exercised, granted, or cancelled in April.</p>\n<p>• The company reported no warrants, convertible securities, Hong Kong depositary receipts, or other equity-linked instruments in issue, and no movements in treasury shares.</p>\n<p>The filing includes standard confirmations that any securities activities comply with the Listing Rules and all relevant legal and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02297","symbol_name":"润迈德-B","start_time":0,"source_url":"","article_id":"1129697107","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129697107","pubTimestamp":1777885546,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Rainmed Medical Limited (Rainmed) filed its monthly return for the period ended 30 April 2026 with the Hong Kong Stock Exchange on 4 May 2026, confirming stable equity metrics and no share-capital...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02297":"润迈德-B"},"translate_title":"Rainmed：2026年4月回报表明股本和2172万份未偿期权不变","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02297":1},"content_text":"Rainmed Medical Limited (Rainmed) filed its monthly return for the period ended 30 April 2026 with the Hong Kong Stock Exchange on 4 May 2026, confirming stable equity metrics and no share-capital movements during the month.\n• Authorised share capital remained at 3.80 billion ordinary shares with a par value of HKD0.0001, equivalent to HKD0.38 million.\n• Issued share capital was unchanged at 1.40 billion shares, and the company held no treasury shares. Rainmed affirmed compliance with the Main Board’s 25% minimum public-float requirement.\n• Under the Pre-IPO Share Option Scheme adopted on 10 December 2021, 21.72 million options with an exercise price of HKD3.90 were outstanding, representing a potential dilution of approximately 1.55% of the current issued share base. No options were exercised, granted, or cancelled in April.\n• The company reported no warrants, convertible securities, Hong Kong depositary receipts, or other equity-linked instruments in issue, and no movements in treasury shares.\nThe filing includes standard confirmations that any securities activities comply with the Listing Rules and all relevant legal and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1129697107","isCrawlerRequest":true}